Neurocutaneous syndromes

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The neurofibromatoses (NFs) encompass several disorders that have as common features both cutaneous pigmented lesions and tumors of neuroectodermal origin. Among this group, NF I and NF II are most common. NF I (also known as peripheral NF or von Recklinghausen's disease) accounts for up to 96% of all NF cases [51]. It constitutes one of the most common inherited neurologic disorders, affecting both sexes and all racial groups equally, with an annual incidence ranging from 1/2,500 to 1/4,000 live births [43]. Its pattern of inheritance is autosomal dominant, with high penetrance and variable expression. Despite this, only half the cases present with a discernible family history - the other half result from new gene mutations. The NF1 tumor suppressor gene has been identified and is located on chromosome 17q11.2. It encodes a large, ubiquitous cytoplasmic protein - neurofibromin - which functions in part to decrease cell proliferation by promoting the inactivation of the p21-ras proto-oncogene [114]. © 2010 Springer-Verlag Berlin Heidelberg.

Cite

CITATION STYLE

APA

Kongkham, P., & Rutka, J. T. (2010). Neurocutaneous syndromes. In Oncology of CNS Tumors (pp. 365–384). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-02874-8_21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free